HGR unknown

back of the envelope valuation., page-9

  1. jdvictoria
    3,648 Posts.
    clock Created with Sketch.
    07/12/07
    13:50
    Post #: 3089307
    Yes, once FDA "approved" that will help, but the next real drivers will be the significantly reduced cost and time to perform a test and the increased sensitivity of the test.

    So, with just the compelling features (reduced time and cost), OraLine should do Ok.

    IMO of course...
    HGR Price at posting: 0.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
NEWS Modelling Confirms Exceptional Heat Sink Performance for VHD Technology
right-arrow Created with Sketch.
HAR Maiden Drilling Program to Commence at Ibel South Gold Project
right-arrow Created with Sketch.
NEWS Copper and Base Metals Targets Confirmed at Minbrie with Drilling Ahead
right-arrow Created with Sketch.
VMM Colossus PFS Unlocks World-Class Project Economics and Positions Viridis for Global Leadership
right-arrow Created with Sketch.
NEWS Gold and Copper Targets Identified by Koonenberry at Prince of Wales Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.